ResMed Q3 Earnings and Revenues Beat, Stock Up in After-Market

ResMed Inc.'s (RMD) adjusted earnings per share (EPS) in the third quarter of fiscal 2025 were $2.37, up 11.3% year over year. The metric beat the Zacks Consensus Estimate by 0.4%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) The adjustments include certain non-recurring expenses/benefits like the amortization of acquired intangibles, along with the income tax effect on those adjustments. GAAP EPS in the reported quarter was$ 2.48, up 21.6% from the year-ago level. Following the ...